In the US, a disease is considered rare when it affects fewer than 200,000 persons, or 1 in every 1500 individuals, with an estimated total of 25 to 30 million Americans overall living with a #raredisease at any given time. Learn more: ajmc.com/view/specialty…

What We’re Reading: #BirdFlu Vaccines; #WalmartHealth Shut Down; Arizona Repeals #AbortionBan . Learn more: ajmc.com/view/what-we-r…

What We’re Reading: FTC Challenges Drugmaker #Patents ; Testing Ground Beef for #BirdFlu ; #RuralAmericans at Higher Early Death Risk

Learn more here: ow.ly/6RmW50RtEwr

The Amer. Urol. Assn. (AUA) 2024 Annual Meeting ( #AUA24 ), which begins on May 3, will highlight the latest innovations and future trends in #urology .

Check out our preview article here to learn more: ow.ly/enJg50RtBW3

How well do you know the April 2024 issue of #AJMC ? Test your knowledge with our short quiz!

To take the quiz, scan the QR code or use this link: ow.ly/qYtO50RtBpy

We are exhibiting at AXS24! Visit us at the MJH booth #1932 during exposition hours at the Wynn in Las Vegas! Stop by to learn more about PTCE's symposia, AJMC, Pharmacy Times, and get some PTCE merch!

MJH Life Sciences® Pharmacy Times AJMC #Asembia2024 #Asembia24 #AXS24

Celebrate National Minority Health Month with us by listening to our latest podcast episode featuring Janine Jelks-Seale, MSPPM, discussing the importance of education and experience in tackling health inequity.

Listen now: bit.ly/3QoSmiK

#NationalMinorityHealthMonth

In this interview, Dr Michael Morse at Duke Cancer Center explains the importance of managing toxicities in the changing #HepatocellularCarcinoma (HCC) treatment landscape to ensure patients have the best possible outcomes in the front line and beyond. ajmc.com/view/dr-michae…

A new court ruling has the future use of skinny labels in question, but skinny-label generics have saved #Medicare a lot of money over 5 years. Read more: ajmc.com/view/competiti…

On a podcast from AJMC, PC3I Associate Director Ravi B. Parikh & Aaron Schwartz discussed their study on the trends of low-value #cancer services among adults with newly diagnosed cancer during the COVID-19 pandemic.

Listen to the episode ⤵️
ajmc.com/view/examining…

What We’re Reading: Mandatory #RespiratoryDisease Reporting Ends; Long #COVID Care Barriers; Regulations on Health App Data

Learn more here: ow.ly/hMGN50RqQC1

An observational study published in Therapeutic Advances in Neurological Disorders found that high rates of hospitalizations among patients with #myastheniagravis ( #MG ) result in significant health care resource utilization and costs.

Learn more here: ow.ly/cL4250RqNyX

While behavioral health care utilization has been rising, the treatment landscape has been worsening. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial #behavioralhealth diagnosis.

Learn more here: ow.ly/mBGb50Rpbva

#AXS24 , the 20th Asembia summit, kicks off today in Las Vegas and will run through Thursday, May 2.

Check out AJMC's preview article to learn more about what to expect from this year's summit: ow.ly/vHNG50Rpbl7

In this #PeerExchange , experts discuss recently approved gene therapies for rare diseases such as hemophilia, spinal muscular atrophy, and Duchenne muscular dystrophy, and review managed care considerations. Watch the series: bit.ly/3JjcGxU #RareDisease #GeneTherapy

Check out the packed agenda for Updates in Value-Based Cancer Care in Austin, Texas. Register now for the May 9 event: ow.ly/LiCR50RgERO

#VitaminD supplementation may decrease in-hospital and intensive care unit (ICU) mortality in patients with chronic obstructive pulmonary disease ( #COPD ), a study found. Read more: ajmc.com/view/vitamin-d…

What happened to low-value cancer care when the COVID-19 pandemic massively disrupted health care delivery? Ravi B. Parikh led this new study in AJMC. We were a bit surprised by the results. ajmc.com/view/trends-in…

The FDA has approved fidanacogene elaparvovec-dzkt ( #Beqvez ; Pfizer), a gene therapy administered in a one-time dose, for certain patients with moderate to severe #hemophiliaB . Learn more: ajmc.com/view/fda-appro…

What We’re Reading: Kaiser Permanente Data Breach; #GSK Sues #Pfizer , #BioNTech ; #HIV Infections via Cosmetic Injections. Read more: ajmc.com/view/what-we-r…